Management of metastatic uveal melanoma: French expert consensus guidelines
Manuel Rodrigues(Inserm), Sophie Piperno‐Neumann(Institut Curie), Marc Pracht(Canadian Partnership Against Cancer), Franck Grillet(Centre Léon Bérard), Agnès Ducoulombier(Centre Antoine Lacassagne), Caroline Dutriaux(Centre Hospitalier Universitaire de Bordeaux), Eve‐Marie Neidhardt(Centre Léon Bérard), Pascale Mariani(Institut Curie), Thomas Ryckwaert(Centre Oscar Lambret), Vincent Servois(Institut Curie)
Cited by 3
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k